Presentation previews · Artwork labels are not verified filling specifications. Purchasing is not available.

AEVIA MED / VIALS
5-Amino-1MQ
Small molecule investigated as an NNMT inhibitor in metabolic models.
Price
Price to confirm
Presentation status
Supplied visual concept. The printed amount is an artwork reference, not confirmation of AEVIA filling, formulation, physical state or use. It is not an application dose.
Compound identity and research context · Separate from the exact product specification
What it is
5-amino-1MQ is a small molecule, not a peptide.
Biological target / research area
Nicotinamide N-methyltransferase (NNMT) inhibition and related metabolic pathways.
What the research examined
Evidence context: preclinical
The selected research concerns cellular and animal models, including obesity-related investigations.
Evidence limitations
These studies do not establish safe human weight loss, an injectable regimen or efficacy of an AEVIA preparation.
5-Amino-1MQ · 10 mg: this printed quantity identifies the artwork presentation. It is not a verified filling specification or an application dose.
Selected references
- Small-molecule NNMT inhibition in obesity-related models (2017) ↗ · Reviewed 14/10/2026
- 5-amino-1MQ metabolic and pharmacokinetic investigation (2024) ↗ · Reviewed 14/10/2026
Composition & specification
Verified product specifications and release documentation are pending. No dosing, preparation or administration instructions are provided.
Storage, safety & batch information
Product-specific storage, expiry and safety documentation must be confirmed for the exact released presentation. Use the exact-presentation batch reference lookup in the product guide. A record match does not authenticate physical contents.